Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanfang-Chunfu Children's Institute of Hematology & Oncology (NCCIHO) is a specialized medical institution and research center located in Dongguan, China, dedicated to the treatment of pediatric blood disorders and cancers. Founded by the renowned hematologist Dr. Li Chunfu, the institute is a global leader in hematopoietic stem cell transplantation (HSCT), particularly for children with thalassemia and refractory leukemia. The facility operates as a high-tech hospital integrating clinical care with advanced research in cell therapies, including CAR-T and haploidentical transplants. NCCIHO is recognized for its high success rates in 'mismatched' transplants and serves as a major referral center for complex pediatric hematology cases in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanfang-Chunfu Children's Institute of Hematology & Oncology.